iQure Pharma
Pre-clinicalDevelops gene therapies for rare genetic diseases using proprietary technology platforms.
Founded
2018
Focus
Small Molecules
About
Develops gene therapies for rare genetic diseases using proprietary technology platforms.
Funding History
2Total raised: $25M
Series A$20MUndisclosedNov 15, 2022
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile